長(zhǎng)期求購(gòu)藥品生產(chǎn)批件/生產(chǎn)線/臨床批件/藥廠轉(zhuǎn)讓信息 1. 如果是單獨(dú)生產(chǎn)批件,可以單品種轉(zhuǎn)讓為宜; MAH制度的省市合作信息亦可。 2. 生產(chǎn)線/藥廠轉(zhuǎn)讓需提供合作模式信息。 3. 需要提供主要負(fù)責(zé)人的職位及手機(jī)號(hào),以便驗(yàn)證信息的真實(shí)和可靠性。 4. 藥智數(shù)據(jù)信息收錄的除外。 5. 提供信息以公司名稱計(jì),給予100元的信息獎(jiǎng)勵(lì)
1.文章名稱: 1).Six-Month Response to Delamanid Treatment in MDR TB Patients.C Hewison, G Ferlazzo, Z Avaliani.2017. 2).Chemical stability of insulin. 3. Influence of excipients, formulation, and pH. Acta Pharm Nord. 1992;4(3):149-58. 3) Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary XDR-TB 2.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序,先到先得,一篇文章可以獲得20元獎(jiǎng)勵(lì)
1.文章名稱: (1).Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. Kawate H, Takayanagi R.Clin Interv Aging. 2011;6:151-60. Epub 2011 Jun 21. Review. (2).J Vasc Surg. 2017 May 19. pii: S0741-5214(17)30915-1. Medical management of claudication. Ratchford EV. (3). Neuropsychiatr Dis Treat. 2017 May 11;13:1281-1302. Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population. Kishi T, Ikuta T, Matsunaga S, Matsuda Y1,, Oya K, Iwata N. (4). BMJ Case Rep. 2017 May 9;2017. pii: bcr-2017-219929. Aripiprazole-induced hypersensitivity pneumonitis. Gunasekaran K, Murthi S, Jennings J, Lone N. (5). Curr Neuropharmacol. 2017 Apr 13. Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity. Tuplin EW1, Holahan MR. (6). Expert Opin Pharmacother. 2017 Feb;18(2):217-223. Brexpiprazole for the treatment of schizophrenia. Hsu WY, Lane HY, Lin CH. (7). J Clin Psychiatry. 2015 Sep;76(9):1232-40. Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study. Thase ME1, Youakim JM, Skuban A, Hobart M, Zhang P, McQuade RD, Nyilas M, Carson WH, Sanchez R, Eriksson H. (8). Ter Arkh. 2017;89(4):101-109. New opportunities for the prevention of gastric cancer. Maev IG, Kazyulin AN. (9). Oral Dis. 2017 May;23(4):511-517. Rebamipide, an anti-ulcerative drug, inhibits induction of salivary dysfunction by benzodiazepines. Ogane M, Okubo M, Yoshikawa M, Shinomiya T, Tsukagoshi E, Kawaguchi M. (10).、Int J Clin Pharm. 2017 May 29.Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients.Huang JJ, Chen B, Hu J. 2.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序,先到先得,一篇文章可以獲得25元獎(jiǎng)勵(lì)
1.文章名稱: (1)Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.M. Biswas (1), G. L. Rogers (1), A. Sherman (1), B. J. Byrne (1), D. M. Markusic (1), H. Jiang (2), R. W. Herzog (1).University of Florida, Department of Pediatrics, Division of Cellular and Molecular Therapy, Gainesville, Florida, USA; (2) Biogen, Cambridge, Massachusetts, USA. 2.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序,先到先得,一篇文章可以獲得25元獎(jiǎng)勵(lì)
1.文章名稱: (1)A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. Scharf, Martin B.; Roth, Thomas; Vogel, Gerald W.; Walsh, James K.The Journal of Clinical Psychiatry, Vol 55(5), May 1994, 192-199. (2)Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II. Sleep: Journal of Sleep Research & Sleep Medicine, Vol 22(Suppl 2), May 1999, S354-S358. 2.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序,先到先得,一篇文章可以獲得25元獎(jiǎng)勵(lì)
1. 如果是單獨(dú)生產(chǎn)批件,可以單品種轉(zhuǎn)讓為宜; MAH制度的省市合作信息亦可。 2. 生產(chǎn)線/藥廠轉(zhuǎn)讓需提供合作模式信息。 3. 需要提供主要負(fù)責(zé)人的職位及手機(jī)號(hào),以便驗(yàn)證信息的真實(shí)和可靠性。 4. 藥智數(shù)據(jù)信息收錄的除外。 5. 提供信息以公司名稱計(jì),給予100元的信息獎(jiǎng)勵(lì)
1.文章名稱: (1)Determination of trace bismuth by atomic fluorescence spectrometry in blood Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2016 Dec 20;34(12):939-941. (2)Bismuth concentration in blood and urine of children treated with ventrisol (polfa) preliminary study. Iwańczak F , Rajska H , Iwańczak B , Górecka H Roczniki Akademii Medycznej w Bialymstoku (1995) [01 Jan 1995, 40(3):685-691]. 2.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序,先到先得,一篇文章可以獲得25元獎(jiǎng)勵(lì)
1、PDF文件,要求:無水印,完整,清晰,來源可靠(非討論稿等),非網(wǎng)上百度所得,盡量為最新版的炮制規(guī)范。 2、45元一個(gè)省份的中藥飲片炮制規(guī)范,目前總共需要5個(gè)省份的資料。 3、需要炮制規(guī)范的省份目錄:甘肅?。?009版),江蘇?。?002版),天津市(2012版),福建省(2012版),青海藏藥